Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
BridgeBio Oncology Therapeutics, Inc (BBOT) had Return on Assets of -29.90% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-134.04M |
|
-- |
|
-- |
|
$145.82M |
|
$-145.82M |
|
$11.78M |
|
$-134.04M |
|
$-134.04M |
|
$-134.04M |
|
$-134.04M |
|
$-134.04M |
|
$-134.04M |
|
$-145.82M |
|
$-145.21M |
|
31.14M |
|
31.14M |
|
$-4.30 |
|
$-4.30 |
|
| Balance Sheet Financials | |
$432.40M |
|
$0.96M |
|
$15.98M |
|
$448.38M |
|
$35.04M |
|
-- |
|
$2.24M |
|
$37.28M |
|
$411.10M |
|
$411.10M |
|
$411.10M |
|
79.99M |
|
| Cash Flow Statement Financials | |
$-113.89M |
|
$73.33M |
|
$383.40M |
|
$30.98M |
|
$373.82M |
|
$342.84M |
|
$5.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-114.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.61% |
|
-32.61% |
|
|
Return on Assets |
-29.90% |
-32.61% |
|
$5.14 |
|
$-3.68 |
|
$-3.66 |
|